within Pharmacolibrary.Drugs.ATC.N;

model N06CA01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.00065,
    adminDuration  = 600,
    adminMass      = 75 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005116666666666667,
    Tlag           = 600,            
    Vdp             = 1.75,
    k12             = 90,
    k21             = 90
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06CA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Amitriptyline is a tricyclic antidepressant used primarily in the treatment of major depressive disorder and various types of chronic pain. Amitriptyline and psycholeptics in combination may refer to co-prescribing of sedative or anxiolytic agents for psychiatric indications. Amitriptyline is an approved drug still in clinical use globally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for amitriptyline and psycholeptics are estimated based on published data for amitriptyline in healthy adult subjects. Sex, age, or comorbidities were not specifically stratified.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06CA01;
